Page last updated: 2024-08-17

quinoxalines and Nasopharyngeal Carcinoma

quinoxalines has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, L; Cao, Y; Huang, BJ; Lin, ZR; Meng, DF; Peng, LX; Qian, CN; Sun, R; Wang, MY; Xie, P; Xu, L; Yang, JP; Zheng, LS	1

Other Studies

1 other study(ies) available for quinoxalines and Nasopharyngeal Carcinoma

Article	Year
PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival. Oncotarget, 2016, May-03, Volume: 7, Issue:18 Topics: Adult; Aged; Animals; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Female; Gene Expression Profiling; Humans; Indolizines; Kaplan-Meier Estimate; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quinoxalines; Reactive Oxygen Species; Signal Transduction; Theranostic Nanomedicine; Transcriptome; Xenograft Model Antitumor Assays	2016

Article

Year

PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival.

Oncotarget, 2016, May-03, Volume: 7, Issue:18

Topics: Adult; Aged; Animals; Biomarkers, Tumor; Carcinoma; Disease-Free Survival; Female; Gene Expression Profiling; Humans; Indolizines; Kaplan-Meier Estimate; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quinoxalines; Reactive Oxygen Species; Signal Transduction; Theranostic Nanomedicine; Transcriptome; Xenograft Model Antitumor Assays

2016